Discover
TWST
Twist Bioscience Corporation
102.25
2 x 75.13
2 x 129.61
bid
ask
-
0.63
0.61%
2 @ 04:00 PM
101.90 -0.35 (0.34%)
| Ytd | 222.35% | |
| 1y | 171.36% |
99.91
day range
104.65
23.30
52 week range
104.65
| Open | 101.16 | Prev Close | 102.88 | Low | 99.91 | High | 104.65 | Mkt Cap | 6.37B |
| Vol | 1.50M | Avg Vol | 1.71M | EPS | -1.32 | P/E | N/A | Forward P/E | -134.78 |
| Beta | 2.21 | Short Ratio | 9.72 | Inst. Own | 123.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 68.89 | 200-d Avg | 45.98 | 1yr Est | 74.10 |
TWST News
benzinga.com
Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $107
Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the
benzinga.com
Barclays Maintains Overweight on Twist Bioscience, Raises Price Target to $95
Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and rais
benzinga.com
Twist Bioscience Files Prospectus For Offering Mixed Shelf; Terms Undisclosed
https://www.sec.gov/Archives/edgar/data/1581280/000110465926075726/tm2617605-1_s3asr.htm
benzinga.com
TD Cowen Maintains Buy on Twist Bioscience, Raises Price Target to $89
TD Cowen analyst Brendan Smith maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the
benzinga.com
Canaccord Genuity Initiates Coverage On Twist Bioscience with Buy Rating, Announces Price Target of
Canaccord Genuity analyst Kyle Mikson initiates coverage on Twist Bioscience (NASDAQ:TWST) with a
benzinga.com
Piper Sandler Initiates Coverage On Twist Bioscience with Overweight Rating, Announces Price Target
Piper Sandler analyst David Westenberg initiates coverage on Twist Bioscience (NASDAQ:TWST) with